UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
March 27, 2023
Accession Number:
0001493152-23-008859
Submission Type:
POS AM
CIK:
0001517681
Company Name:
Propanc Biopharma, Inc.
File Number:
333-238240